Combination of EGFR-TKIs and Chemotherapy as First-Line Therapy for Advanced NSCLC: A Meta-Analysis

The impact of combining epidermal growth factor receptor tyrosine kinase inhibitors (EGFR–TKIs) and chemotherapy as first-line therapy for patients with advanced non-small-cell lung cancer (NSCLC) remains controversial. Therefore, randomized trials that compared this combined regimen with chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: OuYang, Pu-Yun, Su, Zhen, Mao, Yan-Ping, Deng, Wuguo, Xie, Fang-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827342/
https://www.ncbi.nlm.nih.gov/pubmed/24236082
http://dx.doi.org/10.1371/journal.pone.0079000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827342/
https://www.ncbi.nlm.nih.gov/pubmed/24236082
http://dx.doi.org/10.1371/journal.pone.0079000

Ejemplares similares